Review
doi: 10.1038/clpt.2012.102.
Epub 2012 Sep 19.
The TGF-β pathway as an emerging target for Chagas disease therapy
Affiliations
- PMID: 22990752
- DOI: 10.1038/clpt.2012.102
Item in Clipboard
Review
The TGF-β pathway as an emerging target for Chagas disease therapy
Clin Pharmacol Ther.
2012 Nov.
Abstract
Transforming growth factor-β (TGF-β) influences the development of myocardiopathy in Chagas disease through regulation of (i) parasite invasion of heart cells, (ii) an intracellular parasite cycle, (iii) inflammation and immune response, (iv) heart fibrosis and remodeling, and (v) gap junction modulation and heart conduction. In this review, we discuss the rationale for developing TGF-β signaling-interfering therapies as adjuvant approaches for the management of the cardiac alterations of Chagas disease-affected patients.
Similar articles
-
Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):405-13. doi: 10.1016/j.cytogfr.2008.08.002. Epub 2008 Oct 19. Cytokine Growth Factor Rev. 2008. PMID: 18938102 Review.
-
Molecular mechanisms of cardiac electromechanical remodeling during Chagas disease: Role of TNF and TGF-β.Trends Cardiovasc Med. 2017 Feb;27(2):81-91. doi: 10.1016/j.tcm.2016.08.003. Epub 2016 Aug 11. Trends Cardiovasc Med. 2017. PMID: 27622432 Review.
-
In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance.Front Cell Infect Microbiol. 2022 Nov 30;12:1017040. doi: 10.3389/fcimb.2022.1017040. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36530434 Free PMC article.
-
Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease.mBio. 2020 Nov 10;11(6):e01853-20. doi: 10.1128/mBio.01853-20. mBio. 2020. PMID: 33172999 Free PMC article.
-
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease.Mem Inst Oswaldo Cruz. 2022 Feb 25;117:e210395. doi: 10.1590/0074-02760210395. eCollection 2022. Mem Inst Oswaldo Cruz. 2022. PMID: 35239842 Free PMC article.
Cited by
-
Chromatic and Morphological Differentiation of Triatoma dimidiata (Hemiptera: Reduviidae) with Land Use Diversity in El Salvador.Pathogens. 2021 Jun 14;10(6):753. doi: 10.3390/pathogens10060753. Pathogens. 2021. PMID: 34198542 Free PMC article.
-
TGF-β Polymorphisms Are a Risk Factor for Chagas Disease.Dis Markers. 2018 Feb 18;2018:4579198. doi: 10.1155/2018/4579198. eCollection 2018. Dis Markers. 2018. PMID: 29670670 Free PMC article.
-
Clinical features of Chagas disease progression and severity.Lancet Reg Health Am. 2024 Sep 13;37:100832. doi: 10.1016/j.lana.2024.100832. eCollection 2024 Sep. Lancet Reg Health Am. 2024. PMID: 39474468 Free PMC article. Review.
-
Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.Cell Microbiol. 2013 Aug;15(8):1357-66. doi: 10.1111/cmi.12119. Epub 2013 Mar 14. Cell Microbiol. 2013. PMID: 23414299 Free PMC article.
-
Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion.Neural Regen Res. 2015 Mar;10(3):438-44. doi: 10.4103/1673-5374.153693. Neural Regen Res. 2015. PMID: 25878593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
